Addiction Treatment in Nassau for Philadelphia Residents
For U.S. residents: DeBinge advises patients to plan for the implant treatment and travel to The Bahamas as out-of-pocket expenses. The O’Neil Long-Acting Naltrexone Implant is not FDA-approved for standard clinical use in the United States, and U.S. health insurance generally does not cover this t
DeBinge opioid transition: When travelling to DeBinge in The Bahamas for OLANI treatment, there is no requirement to complete a separate opioid-free waiting window before arrival. DeBinge uses a medically supervised 4-to-5-day buprenorphine transition. Buprenorphine is introduced to bridge the patient away from full-agonist opioids, stabilised and tapered over the first several days, and the O’Neil Long-Acting Naltrexone Implant is typically inserted around day 4 or 5 while buprenorphine is still being tapered. The planned overlap continues as buprenorphine clears and the implant gradually releases naltrexone. This pathway is clinician-supervised because mistimed naltrexone exposure can precipitate withdrawal.
Based on DeBinge’s clinical experience in The Bahamas since 2018, the implant typically provides its strongest craving and relapse-prevention support on average 9 months, while clinically meaningful opioid-receptor blockade may persist for longer, in some patients up to about 15 months. This longer blockade may continue to reduce opioid effects and overdose risk.
Ongoing recovery: The implant is not a cure. The DeBinge programme includes a full year of professional counselling after implantation to address the behavioural and psychological side of addiction.
reatment or associated travel. Patients should confirm any individual benefits directly with their insurer.DeBinge provides private addiction treatment in Nassau for Philadelphia and Pennsylvania residents considering specialist care outside their usual environment. Consultation, clinical assessment and treatment preparation begin before international travel is arranged.
Nonstop Philadelphia–Nassau service is currently listed as seasonal. If nonstop service is not available on the dates that fit the patient’s treatment plan, the patient is responsible for arranging a suitable alternative itinerary. Current routes should always be checked rather than assuming a particular connection is available.
This page is designed to help residents of Philadelphia and Pennsylvania understand how they can access treatment in Nassau. Treatment timing should be established before travel arrangements are finalized.
Considering Treatment Outside Pennsylvania
Philadelphia and the wider Pennsylvania region have established hospitals, addiction specialists, outpatient services, medication programs and residential treatment options. For many people, appropriate care close to home is the right choice.
Other patients deliberately consider treatment elsewhere because they want to discuss a specialist naltrexone-based approach, have previously tried treatment locally or feel that temporarily leaving their usual environment could help them focus on the next stage of recovery.
Treatment in The Bahamas is not automatically better than treatment in Pennsylvania. The relevant question is whether the DeBinge model is clinically suitable for the individual and whether there is a realistic plan for continuing recovery after returning home.
Consider whether naltrexone fits the situation
Long-acting naltrexone may be considered for suitable patients following medical assessment, but it is not appropriate for everyone.
Create temporary distance from familiar patterns
Some patients value a treatment period away from locations, routines and social circumstances closely connected with substance use.
Think beyond the treatment stay
Counselling, routines, appropriate local support and planning for familiar triggers remain important after returning to Pennsylvania.
Philadelphia to Nassau
Seasonal nonstop service may make direct Philadelphia-to-Nassau travel possible during applicable schedule periods. It should not, however, determine the medical timetable for treatment.
How the DeBinge Programme Works
The first stages take place before the patient leaves Philadelphia. International travel comes after the treatment pathway has been discussed.
Private consultation
Discuss current substance use, medications, previous treatment and what the patient wants to change.
Assessment and preparation
Consider clinical suitability, physical dependence and what needs to happen before treatment.
Treatment in Nassau
Travel when clinically appropriate and follow the individualized treatment pathway.
Recovery in Pennsylvania
Continue counselling, recovery planning and appropriate support after returning home.
Could Naltrexone Be Part of the Treatment Plan?
Naltrexone is an established medication used in alcohol use disorder and opioid use disorder. Whether it is appropriate depends on the individual patient and should be considered after medical assessment.
Current substance use
The substances involved, pattern of use and possible physical dependence influence treatment planning.
Current medications
Prescription medication, addiction medications and other relevant substances should be reviewed.
Previous treatment
Earlier detoxification, rehabilitation, outpatient treatment or counselling can provide useful context.
Withdrawal history
Previous withdrawal is particularly important to discuss where alcohol or opioids are involved.
Medical circumstances
Relevant physical and mental-health information should form part of the wider assessment.
Recovery environment
Family, work, housing, routines and support in Pennsylvania may influence the longer-term plan.
Opioid Treatment for Philadelphia Residents
Naltrexone blocks opioid receptors and may form one part of treatment for appropriately selected people with opioid use disorder.
Someone who remains physically dependent on opioids requires appropriate preparation before receiving naltrexone. Starting naltrexone too early can precipitate significant withdrawal, so suitability and timing need clinical assessment.
Methadone, buprenorphine, extended-release injectable naltrexone, residential rehabilitation and outpatient treatment are among other evidence-based options. Different patients may benefit from different approaches.
Explore opioid treatment informationAlcohol Treatment for Pennsylvania Residents
Naltrexone may help some people with alcohol use disorder by reducing aspects of alcohol reward and supporting reduced drinking or abstinence within a broader treatment plan.
Naltrexone does not treat acute alcohol withdrawal. A patient who may be physically dependent on alcohol should not abruptly stop drinking simply because international treatment has been arranged.
Alcohol withdrawal can be medically serious in some circumstances, so withdrawal risk and treatment timing should be considered before travelling.
Explore alcohol treatment informationEstablish the Clinical Plan Before Arranging Travel
A free consultation allows the patient or family to explain the current situation and understand whether DeBinge may be relevant before booking international travel.
What Happens Before You Travel
The clinical pathway should be understood before the patient leaves Pennsylvania. A convenient seasonal flight does not determine whether the patient is medically ready for treatment.
The team needs relevant information about substance use, current medication, previous treatment and medical history. If physical withdrawal may be significant, appropriate preparation and travel timing need particular attention.
Patients should also think about responsibilities at home, travel documentation, the likely stay in Nassau and what support will be available after returning.
For more practical information, review the U.S. guide to travelling to Nassau for treatment .
Before finalizing the trip, discuss:
- Current alcohol or drug use.
- Current medications.
- Previous withdrawal experiences.
- Previous addiction treatment.
- Relevant medical concerns.
- Whether additional preparation is required.
- The likely treatment timeframe.
- The return-home recovery plan.
Do Not Travel Through Medically Significant Withdrawal
Patients should not assume they can safely fly to Nassau while experiencing significant withdrawal. Alcohol withdrawal can become dangerous in some people, while opioid-dependent patients require appropriate preparation before naltrexone can be considered.
Severe withdrawal, seizures, difficulty breathing, unconsciousness, suspected overdose, severe confusion or another immediate medical emergency requires urgent local medical attention rather than waiting for international travel.
What Happens During Treatment in The Bahamas?
The treatment sequence depends on the individual plan. DeBinge does not assume that every person arriving from Philadelphia requires the same preparation, treatment or length of stay.
Confirm readiness
Relevant medical review, assessment or testing may be completed before treatment proceeds where required.
Follow the individual pathway
For suitable patients, treatment may include sustained-release naltrexone together with appropriate medical and nursing care.
Prepare for Pennsylvania again
Counselling and planning can address routines, relationships, stressors and the support needed after the patient returns home.
Returning Home and Continuing Recovery
A temporary change of environment can create useful space for treatment, but recovery eventually has to work again in Philadelphia and the patient’s normal life.
Prepare for the Return Before Leaving Nassau
Medication may support recovery for a suitable patient, but it does not automatically change relationships, routines, stress responses or familiar environments associated with substance use.
Continue counselling
Counselling can address emotional triggers, coping strategies, relationships and behavioral patterns that medication alone cannot change.
Use appropriate local care
Some patients may need Pennsylvania-based doctors, therapists or other appropriately qualified professionals after returning home.
Identify familiar triggers
Review people, places, routines and situations that have repeatedly been associated with substance use.
Create daily structure
Sleep, work, exercise, appointments and constructive activities can support a more stable routine.
Clarify family support
Family members can provide appropriate support without being made responsible for every decision.
Plan for difficulties
The patient should know where to seek appropriate help if substance use resumes or significant medical or mental-health concerns develop.
Philadelphia Families Can Speak With DeBinge First
Parents, spouses and partners are often the people researching treatment before the patient is ready to make a decision. They may be trying to understand what options remain after previous treatment, repeated substance use or difficulty maintaining recovery.
Family members can contact DeBinge to ask how the programme works and what would happen if the patient agrees to an assessment.
Relatives may provide useful background about previous treatment, withdrawal experiences or patterns of substance use, but the patient’s own clinical assessment remains necessary before treatment suitability can be determined.
Read the DeBinge guide for familiesWhat If Treatment Has Already Been Tried?
Previous treatment can provide useful information about what has helped and what has been difficult.
A person may have done well during residential treatment but struggled after returning to familiar surroundings. Another may have stopped medication or counselling. Someone else may want to explore a treatment approach that has not previously been considered.
Reviewing these details can help shape a more realistic recovery plan rather than simply repeating the same approach.
Questions worth reviewing
- Which treatment was previously used?
- What appeared to help?
- What happened after treatment?
- Was medication continued?
- Was counselling maintained?
- Which situations preceded returning to substance use?
- What support existed at home?
- What needs to be different this time?
Review the Clinical Background and Research
Patients and families considering treatment outside Pennsylvania should be able to review information about the treatment model and clinical background before deciding whether to proceed.
Dr Fergus Law
Review DeBinge’s clinical profile for Dr Fergus Law and information relating to his work in addiction psychiatry and substance misuse.
View Dr Fergus Law’s clinical profileNaltrexone Implant Knowledge Library
Explore research and educational information concerning naltrexone, sustained-release formulations, opioid use disorder and alcohol use disorder.
Explore the naltrexone research libraryInformation for U.S. residents
Review the broader DeBinge pathway for Americans, including travel planning, family guidance and recovery after treatment.
View treatment information for U.S. residentsDiscuss Whether the Programme May Be Appropriate
A free consultation allows the patient or family to explain the current situation, ask about naltrexone suitability and understand what assessment or preparation may be required before travelling to Nassau.
Addiction Treatment From Philadelphia to Nassau: FAQs
Does DeBinge operate an addiction treatment facility in Philadelphia?
Is there a nonstop flight from Philadelphia to Nassau?
What if nonstop Philadelphia–Nassau service is not available on my treatment dates?
Why might someone consider treatment outside Pennsylvania?
How do I know whether naltrexone is appropriate for me?
Can I travel to Nassau while withdrawing?
What happens after I return to Philadelphia?
Find Out Whether Treatment in Nassau May Be Appropriate
Begin by discussing the substance involved, current medications, previous treatment, relevant medical circumstances and what the patient wants to change. If DeBinge may be relevant, the clinical and practical steps can be planned before travelling from Philadelphia.
Medical information: This page provides general educational information and does not replace individual medical assessment, diagnosis or treatment. Naltrexone may be appropriate for some people with alcohol use disorder or opioid use disorder, but treatment selection depends on individual clinical circumstances. Implant formulations have formulation-specific evidence and regulatory status. DeBinge treatment takes place in Nassau, The Bahamas.
Travel information: Philadelphia–Nassau nonstop service is currently seasonal. Airline routes, operating dates and schedules can change. If nonstop service is unavailable, patients should check current travel options and arrange an appropriate itinerary rather than relying on a specific connection described online. Treatment timing should be discussed before travel is booked.
Emergency information: Suspected overdose, difficulty breathing, unconsciousness, seizures, severe withdrawal, severe confusion or another immediate medical emergency requires urgent local assistance rather than international travel. In the United States call 911. For an immediate suicide or mental-health crisis, call or text 988.